Gravar-mail: ACTR-07. LIMITED IMPACT OF EXTENDED ADJUVANT TEMOZOLOMIDE BEYOND 12 CYCLES IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMAS